首页> 美国卫生研究院文献>Advances in Hematology >Real-World Treatment Patterns Outcomes and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France

【2h】

Real-World Treatment Patterns Outcomes and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France

机译：复发或难治性多发性骨髓瘤的现实世界治疗模式结果和医疗资源利用：来自法国病历审查的证据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Limited data are available from real-world practices in Europe describing prevailing treatment patterns and outcomes in relapsed/refractory multiple myeloma (RRMM), particularly by cytogenetic risk.

机译：背景技术可以从欧洲的实际操作中获得有限的数据，这些数据描述了复发/难治性多发性骨髓瘤（RRMM）的主要治疗方式和结局，尤其是通过细胞遗传学风险。

著录项

期刊名称 Advances in Hematology
作者
Huamao Mark Lin; Keith L. Davis; James A. Kaye; Katarina Luptakova; Saurabh P. Nagar; Mohamad Mohty;
展开▼
作者单位

展开▼
年(卷),期 2019(2019),-1
年度 2019
页码 4625787
总页数 12
原文格式 PDF
正文语种
中图分类血液学检验;
关键词

相似文献

外文文献
中文文献
专利

1. Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France [J] . Huamao Mark Lin, Keith L. Davis, James A. Kaye, Advances in hematology . 2019,第3期

机译：在复发或难治性多发性骨髓瘤中的现实世界治疗模式，结果和医疗保健资源利用：来自法国的医疗记录评论的证据
2. Treatment Patterns and Healthcare Resource Utilization in Patients with Relapsed/Refractory Acute Myeloid Leukemia and a Subset with IDH1-Mutation: A United States Medical Chart Review Study [J] . Griffin James D., Storm Mike, Wilhelm Ken, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：复发/难治性急性髓性白血病患者的治疗模式和医疗保健资源利用和IDH1-突变的子集：美国医学图表审查研究
3. Treatment Sequencing in Patients with Relapsed/Refractory Multiple Myeloma after Daratumumab Treatment: Real-World Findings from a Pooled Data Analysis of Preamble and the Mckesson Electronic Medical Record Database [J] . Vij Ravi, Chen Clara, Yasenchak Christopher A., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：达拉姆宫治疗后复发/难治性多发性骨髓瘤患者的治疗测序：来自汇流数据分析的真实世界发现，序言和MCKESSON电子医疗记录数据库
4. Mining Electronic Medical Records to Explore the Linkage between Healthcare Resource Utilization and Disease Severity in Diabetic Patients [C] . Lee Noah, Laine Andrew F., Hu Jianying, 2011 First IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology . 2011

机译：挖掘电子病历以探索糖尿病患者医疗资源利用与疾病严重性之间的联系
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. Evaluating Treatment Patterns Relapses Healthcare Resource Utilization and Costs Associated with Disease-Modifying Treatments for Multiple Sclerosis in DMT-Naïve Patients [O] . Leorah Freeman, Arianna Kee, Marc Tian, 2021

机译：评估治疗模式复发医疗资源利用率和与DMT-Naïve患者多发性硬化症的疾病修饰治疗相关的成本
7. PSY133 Assessment of Real-World Treatment Patterns and Outcomes In Relapsed or Refractory Multiple Myeloma: Evidence From A Brief Multi-Country Survey of European Physicians [O] . Davis KL, Lin HM, Hui A, 2015

机译：PSY133对复发或难治性多发性骨髓瘤的现实世界治疗模式和结果的评估：来自欧洲医师的简短多国调查的证据

Real-World Treatment Patterns Outcomes and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France

摘要

著录项

相似文献

相关主题

期刊订阅